CrossAmerica's EBITDA Decline Looks Great-But the Real Question Is Whether the Cash Stays Real

CrossAmerica's Q2 showed better cash coverage, but the 9.6% yield still signals risk

With a 9.6% yield, CrossAmerica is paying investors to accept real risk, not simply rewarding them for sitting still.

That is the core tension in the latest quarter. Bulls can point to meaningful operating improvement from the first quarter. But the headline figure often cited from the prior-year comparison tells the wrong story: CrossAmerica actually reported Adjusted EBITDA of $37.1 million in Q2 2025, down from $42.6 million a year earlier. The more encouraging change was on coverage. The partnership said the Distribution Coverage Ratio for the Second Quarter of 2025 was 1.12 times, up from 1.30 times for the Second Quarter of 2024. In simple terms, cash relative to the distribution improved from one quarter to the last, even though the year-over-year EBITDA reading was weaker, not stronger.

That matters because a better coverage ratio is not the same as hardened proof. The stock market's reaction captured that mix of interest and caution: a 2.3% post-earnings gain, then -1.3% drift. High-yield stocks rarely rerate on a single quarter that merely looks better. They tend to rerate only when investors start to believe the cash stream is durable and the balance sheet is getting easier to carry.

So the real watchpoint is cash quality. CrossAmerica also reported Distributable Cash Flow of $22.4 million and said it reduced debt by more than $50 million, which are constructive signs if they continue. If that cash generation holds, the yield can remain a fair return for owning a less loved name. If EBITDA and distributable cash fail to hold their ground, the yield starts to look less like income and more like stress compensation.